ID: h-59dcb68e7d
Hypothesis

TREM2-Independent Microglial Activation via CSF1R

Identification of a TREM2-independent disease-associated microglial (DAM) trajectory in late-stage AD.
🧬 CSF1R🩺 neurodegeneration🎯 Composite 66%💱 $0.58▼11.2%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.72 (15%) Evidence 0.68 (15%) Novelty 0.85 (12%) Feasibility 0.65 (12%) Impact 0.70 (12%) Druggability 0.72 (10%) Safety 0.52 (8%) Competition 0.75 (6%) Data Avail. 0.60 (5%) Reproducible 0.62 (5%) KG Connect 0.33 (8%) 0.659 composite

🧪 Overview

Identification of a TREM2-independent disease-associated microglial (DAM) trajectory in late-stage AD. Single-cell analysis reveals microglial subclusters expressing elevated APOE, CSF1R, and CX3CR1 without TREM2 activation markers, suggesting an alternative activation pathway driving neuroinflammation through C3 upregulation.

🧬 Mechanism

🔗 Mechanism from KG for CSF1R

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    CSF1R["CSF1R"] -->|regulates| neuroinflammation["neuroinflammation"]
    CSF1R_1["CSF1R"] -->|regulates| microglial_activation["microglial_activation"]
    CSF1R_2["CSF1R"] -->|regulates| Microglial_activation["Microglial activation"]
    style CSF1R fill:#ce93d8,stroke:#333,color:#000
    style neuroinflammation fill:#4fc3f7,stroke:#333,color:#000
    style CSF1R_1 fill:#ce93d8,stroke:#333,color:#000
    style microglial_activation fill:#4fc3f7,stroke:#333,color:#000
    style CSF1R_2 fill:#ce93d8,stroke:#333,color:#000
    style Microglial_activation fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
DAM progression documented in AD cortex
Supports
TREM2-dependent DAM identified in mouse models
Supports
APOE4 drives microglial inflammation
Contradicts
TREM2-dependent and independent DAM converge on lipid metabolism signatures
Contradicts
APOEε4 microglial inflammation requires TREM2 signaling
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — CSF1R

🧬 PDB 4R7H Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for CSF1R →

No DepMap CRISPR Chronos data found for CSF1R.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.6%
Volatility
Low
0.0024
Events (7d)
2
Price History
▼11.2%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF pharmacologic CSF1R inhibition (PLX3397 or BLZ945, 100mg/kg daily for 4-8 weeks) is administered in a late-stage AD mouse model (5xFAD at 9 months), THEN C3 expression in isolated CD11b+ microglial≥50% reduction in microglial C3 mRNA and protein levels following CSF1R blockade in late-stage AD— no observation —pending0.60
IF TREM2 is genetically knocked out in 5xFAD mice (crossed with Trem2-/-), THEN single-cell RNA sequencing at 9 months will reveal a microglial subcluster expressing elevated APOE, CSF1R, and CX3CR1 (Identical DAM subcluster with high APOE, CSF1R, CX3CR1 and low TREM2 activation markers in TREM2 knockout AD mice— no observation —pending0.55
🔮 Falsifiable Predictions (2)
pendingconf 60%
IF pharmacologic CSF1R inhibition (PLX3397 or BLZ945, 100mg/kg daily for 4-8 weeks) is administered in a late-stage AD mouse model (5xFAD at 9 months), THEN C3 expression in isolated CD11b+ microglial cells will decrease by ≥50% compared to vehicle-treated controls, as measured by qPCR and ELISA.
Predicted outcome: ≥50% reduction in microglial C3 mRNA and protein levels following CSF1R blockade in late-stage AD
Falsification: No significant change or increase in C3 expression after CSF1R inhibition, indicating the pathway operates independently of CSF1R signaling
pendingconf 55%
IF TREM2 is genetically knocked out in 5xFAD mice (crossed with Trem2-/-), THEN single-cell RNA sequencing at 9 months will reveal a microglial subcluster expressing elevated APOE, CSF1R, and CX3CR1 (log2FC ≥1.5 vs. wildtype), indistinguishable from the TREM2-independent trajectory observed in human
Predicted outcome: Identical DAM subcluster with high APOE, CSF1R, CX3CR1 and low TREM2 activation markers in TREM2 knockout AD mice
Falsification: Absence of APOE/CSF1R/CX3CR1 co-expressing microglial subcluster in Trem2-/- 5xFAD mice; or presence of this cluster only in TREM2-intact animals, disproving TREM2-independence
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.